{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:41:08Z","timestamp":1768516868543,"version":"3.49.0"},"reference-count":24,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Buddhist Hualien Tzu Chi General Hospital","award":["TCRD113-075"],"award-info":[{"award-number":["TCRD113-075"]}]},{"name":"Buddhist Hualien Tzu Chi General Hospital","award":["TCMMMP104"],"award-info":[{"award-number":["TCMMMP104"]}]},{"name":"Buddhist Tzu Chi Medical Foundation","award":["TCRD113-075"],"award-info":[{"award-number":["TCRD113-075"]}]},{"name":"Buddhist Tzu Chi Medical Foundation","award":["TCMMMP104"],"award-info":[{"award-number":["TCMMMP104"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The detection of ovarian cancer remains challenging due to the lack of reliable serum biomarkers that reflect malignant transformation rather than mere tumor presence. We developed a novel biotest using an immortalized human fallopian tube epithelial cell line (TY), which exhibits anchorage-independent growth (AIG) in response to cancer-associated serum factors. Methods: Sera from ovarian and breast cancer patients, non-cancer controls, and ID8 ovarian cancer-bearing mice were tested for AIG-promoting activity in TY cells. Results: TY cells (passage 96) effectively distinguished cancer sera from controls (68.50 \u00b1 2.12 vs. 17.50 \u00b1 3.54 colonies, p &lt; 0.01) and correlated with serum CA125 levels (r = 0.73, p = 0.03) in ovarian cancer patients. Receiver operating characteristic (ROC) analysis showed high diagnostic accuracy (AUC = 0.85, cutoff: 23.75 colonies). The AIG-promoting activity was mediated by HGF\/c-MET and IGF\/IGF-1R signaling, as inhibition of these pathways reduced phosphorylation and AIG. In an ID8 mouse ovarian cancer model, TY-AIG colonies strongly correlated with tumor burden (r = 0.95, p &lt; 0.01). Conclusions: Our findings demonstrate that the TY cell-based AIG assay is a sensitive and specific biotest for detecting ovarian cancer and potentially other malignancies, leveraging the fundamental hallmark of malignant transformation.<\/jats:p>","DOI":"10.3390\/diagnostics15151975","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:25:11Z","timestamp":1754486711000},"page":"1975","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Novel Serum-Based Bioassay for Quantification of Cancer-Associated Transformation Activity: A Case\u2013Control and Animal Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9472-0950","authenticated-orcid":false,"given":"Aye Aye","family":"Khine","sequence":"first","affiliation":[{"name":"Center for Prevention and Therapy of Gynecological Cancers, Department of Research, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Shun","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Prevention and Therapy of Gynecological Cancers, Department of Research, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Chu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Shuo","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Dalin Tzu Chi Hospital, Dalin 90749, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Hsi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"},{"name":"Institute of Medical Science, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Chao","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan"},{"name":"School of Medicine, College of Medicine, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-2681","authenticated-orcid":false,"given":"Tang-Yuan","family":"Chu","sequence":"additional","affiliation":[{"name":"Center for Prevention and Therapy of Gynecological Cancers, Department of Research, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"},{"name":"Department of Obstetrics & Gynecology, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan"},{"name":"Institute of Medical Science, Tzu Chi University, Hualien 97004, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ogc.2007.09.004","article-title":"Cervical Cancer Prevention\u2014Cervical Screening: Science in Evolution","volume":"34","author":"Safaeian","year":"2007","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gutjnl-2016-312712","article-title":"Effectiveness of Screening Colonoscopy in Reducing the Risk of Death from Right and Left Colon Cancer: A Large Community-Based Study","volume":"67","author":"Doubeni","year":"2018","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An Integrated Review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41408-021-00460-0","article-title":"Incidence and Clinical Characteristics of Multiple Myeloma with Low M-Protein Levels and Normal Values of Hemoglobin, Creatinine, Calcium, and Serum Free Light Chain Ratio","volume":"11","author":"Szabo","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0090-8258(74)90055-9","article-title":"Gestational Trophoblastic Neoplasms","volume":"2","author":"Hilgers","year":"1974","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0065-230X(08)60523-0","article-title":"Alpha-Fetoprotein in Ontogenesis and Its Association with Malignant Tumors","volume":"14","author":"Abelev","year":"1971","journal-title":"Adv. Cancer Res."},{"key":"ref_7","first-page":"14141","article-title":"Early Diagnosis of Ovarian Cancer: Serum HE4, CA125, and ROMA Model","volume":"13","author":"Wang","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian Cancer Population Screening and Mortality After Long-Term Follow-Up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No Benefit from Combining HE4 and CA125 as Ovarian Tumor Markers in a Clinical Setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a Diagnostic Test in Ovarian Cancer: Prospective Validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Cadron","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","article-title":"Mutagenic, Surviving, and Tumorigenic Effects of Follicular Fluid in the Context of p53 Loss: Initiation of Fimbria Carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ebiom.2019.01.061","article-title":"IGF-Axis Confers Transformation and Regeneration of Fallopian Tube Fimbria Epithelium upon Ovulation","volume":"41","author":"Hsu","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.neo.2021.09.006","article-title":"Ovulation Sources Coagulation Protease Cascade and Hepatocyte Growth Factor to Support Physiological Growth and Malignant Transformation","volume":"23","author":"Huang","year":"2021","journal-title":"Neoplasia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12935-024-03614-9","article-title":"Epidermal Growth Factor Receptor Ligands Enriched in Follicular Fluid Exosomes Promote Oncogenesis of Fallopian Tube Epithelial Cells","volume":"24","author":"Khine","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hsu, C.F., Chen, P.C., Seenan, V., Ding, D.C., and Chu, T.Y. (2021). Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13030468"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Miyamoto, T., Murphy, B., and Zhang, N. (2023). Intraperitoneal Metastasis of Ovarian Cancer: New Insights on Resident Macrophages in the Peritoneal Cavity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1104694"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1002\/1878-0261.12949","article-title":"Prognostic Relevance of Longitudinal HGF Levels in Serum of Patients with Ovarian Cancer","volume":"15","author":"Klotz","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/or.2015.4048","article-title":"High IGF2 Expression Is Associated with Poor Clinical Outcome in Human Ovarian Cancer","volume":"34","author":"Dong","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1677\/joe.0.1490367","article-title":"Involvement of IGF-II in Human Cancer","volume":"149","author":"Toretsky","year":"1996","journal-title":"J. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cas.13156","article-title":"Hepatocyte Growth Factor\/MET in Cancer Progression and Biomarker Discovery","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1158\/1055-9965.1759.13.11","article-title":"Serum Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins, and Breast Cancer Risk in Postmenopausal Women","volume":"13","author":"Flyvbjerg","year":"2004","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3892\/mmr.2014.2808","article-title":"Expression of Hepatocyte Growth Factor in Breast Cancer and Its Effect on Prognosis and Sensitivity to Chemotherapy","volume":"11","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/15\/1975\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:40Z","timestamp":1760034280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/15\/1975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":24,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["diagnostics15151975"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15151975","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}